Sfoglia per Autore
Absolute configuration of Spirolaxine, a Metabolite of Sporotrichum laxum
2002-01-01 Candiani, Gabriele; Malpezzi, Luciana; G., Nasini; G., Giannini
Structure and absolute configuration of acetosellin, a new polyketide from a phytotoxic strain of Cercosporella acetosella
2002-01-01 G., Nasini; A., Arnone; G., Assante; Candiani, Gabriele; O., VAJNA DE PAVA
Isolation and structure elucidation of new sesquiterpenes of protoilludane origin from the fungus Clavicorona divaricata
2003-01-01 A., Arnone; Candiani, Gabriele; G., Nasini; R., Sinisi
Chrysanthones, a new source of fungal metabolites with potential antitumoral and antiangiogenesis properties
2003-01-01 G., Giannini; S., Penco; C., Pisano; T., Riccioni; G., Nasini; Candiani, Gabriele
Cardiac glutathione content determines cardiac function alterations in hypertensive L-NAME rat
2004-01-01 C., Adamy; M., Bourraindeloup; M., Cailleret; Candiani, Gabriele; M. C., Bourin; T., Badoual; J. B., Su; S., Adubeiro; J. L., DUBOIS RANDÉ; L., Hittinger; F., Pecker
Cardiac glutathione content determines cardiac function alterations in hypertensive L-NAME rat
2004-01-01 C., Adamy; M., Bourraindeloup; M., Cailleret; Candiani, Gabriele; M. C., Bourin; T., Badoual; J. B., Su; S., Adubeiro; J. L. DUBOIS RANDÉ L., Hittinger; F., Pecker
Effect of NAC given as a therapeutic treatment against hypertension-induced cardiac remodeling
2004-01-01 Candiani, Gabriele; C., Adamy; M., Bourraindeloup; M., Cailleret; M. C., Bourin; J. B., Su; S., Adubeiro; J. L., DUBOIS RANDE; L., Hittinger; F., Pecker
a-trifluoromethyl-a-amino-b-sulphone hydroxamate inhibits MMP-2, -3, and -9 activity
2004-01-01 R., Parente; Candiani, Gabriele; M., Canavesi; F., Pecker; Sani, Monica; M., Zanda; S., Bellosta
N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats
2004-01-01 M., Bourraindeloup; C., Adamy; Candiani, Gabriele; M., Cailleret; M. C., Bourin; T., Badoual; J. B., Su; S., Adubeiro; F., ROUDOT THORAVAL; J. L., DUBOIS RANDE; L., Hittinger; F., Pecker
The cytosolic phospholipase A2 pathway, a safeguard of beta 2-adrenergic cardiac effects in rat
2005-01-01 B., AIT MAMAR; M., Cailleret; C., RUCKER MARTIN; A., Bouabdallah; Candiani, Gabriele; C., Adamy; P., Duvaldestin; F., Pecker; N., Defer; C., Pavoine
The cytosolic phospholipase A2 pathway, a safeguard of beta 2-adrenergic cardiac effects in rat
2005-01-01 B., AIT MAMAR; M., Cailleret; C., RUCKER MARTIN; A., Bouabdallah; Candiani, Gabriele; C., Adamy; P., Duvaldestin; F., Pecker; N., Defer; C., Pavoine
MS 560, a new selective inhibitor of metalloproteinase-3 and –9 activity
2005-01-01 S., Bellosta; R., Parente; Candiani, Gabriele; M., Canavesi; F., Pecker; Sani, Monica; M., Zanda
KI-LmnaH222P mouse model: Progression of muscular dystrophy and cardiomyopathy is associated with tumor necrosis factor alpha expression
2005-01-01 V., Decostre; C., Adamy; C., Massart; T., Arimura; Candiani, Gabriele; S., Varnous; F., Pecker; G., Bonne
Progression of dilated cardiomyopathy due to LMNA mutation is associated with Tumor Necrosis Factor alpha expression. Treatment with N-acetylcysteine
2005-01-01 C., Adamy; T., Arimura; Candiani, Gabriele; S., Varnous; C., Massart; V., Decostre; F., Pecker; G., Bonne
Tumor Necrosis Factor alpha converting enzyme (TACE), a newly identified target of MMP-3
2005-01-01 Candiani, Gabriele; C., Adamy; M. C., Bourin; M., Bourraindeloup; N., Defer; C., Pavoine; L., Hittinger; F., Pecker
Treatment of chronic heart failure with N-acetylcysteine: improvement of cardiac function via compensation for glutathione depletion and TNF imbalance
2005-01-01 C., Adamy; P., Mulder; Candiani, Gabriele; N., ANDRIEU ABADIE; C., Pavoine; N., Defer; T., Levade; C., Thuillez; L., Hittinger; F., Pecker
Progression of muscular dystrophy and cardiomyopathy due to LMNA mutation is associated with Tumor Necrosis Factor alpha expression. Treatment with N-acetylcysteine (NAC)
2005-01-01 C., Adamy; T., Arimura; Candiani, Gabriele; V., Decostre; S., Varnous; C., Massart; F., Pecker; G., Bonne
Implication of Tumor Necrosis Factor alpha in dilated cardiomyopathy due to LMNA mutation
2005-01-01 C., Adamy; T., Arimura; Candiani, Gabriele; S., Varnous; C., Massart; V., Decostre; F., Pecker; G., Bonne
Selective inhibition of MMP-3 and MMP-9 by an amino-sulphone-hydroxamate derivative
2005-01-01 R., Parente; Candiani, Gabriele; M., Canavesi; F., Pecker; Sani, Monica; M., Zanda; S., Bellosta
Increased Tumor Necrosis Factor alpha expression in dilated cardiomyopathy due to LMNA mutation is prevented by N-acetylcysteine treatment
2005-01-01 C., Adamy; T., Arimura; V., Decostre; Candiani, Gabriele; S., Varnous; C., Massart; F., Pecker; G., Bonne
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile